Works by Nguyen, Holly M.

Results: 18

Sequencing SARS-CoV-2 from antigen tests.

Published in:

PLoS ONE, 2022, v. 17, n. 2, p. 1, doi. 10.1371/journal.pone.0263794

By:

Nazario-Toole, Ashley;
Nguyen, Holly M.;
Xia, Hui;
Frankel, Dianne N.;
Kieffer, John W.;
Gibbons, Thomas F.

Publication type:

Article

Dual targeting of the androgen receptor and PI3K/AKT/mTOR pathways in prostate cancer models improves antitumor efficacy and promotes cell apoptosis.

Published in:

Molecular Oncology, 2024, v. 18, n. 3, p. 726, doi. 10.1002/1878-0261.13577

By:

Sugawara, Tatsuo;
Nevedomskaya, Ekaterina;
Heller, Simon;
Böhme, Annika;
Lesche, Ralf;
von Ahsen, Oliver;
Grünewald, Sylvia;
Nguyen, Holly M.;
Corey, Eva;
Baumgart, Simon J.;
Georgi, Victoria;
Pütter, Vera;
Fernández‐Montalván, Amaury;
Vasta, James D.;
Robers, Matthew B.;
Politz, Oliver;
Mumberg, Dominik;
Haendler, Bernard

Publication type:

Article

Subtype heterogeneity and epigenetic convergence in neuroendocrine prostate cancer.

Published in:

Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-26042-z

By:

Cejas, Paloma;
Xie, Yingtian;
Font-Tello, Alba;
Lim, Klothilda;
Syamala, Sudeepa;
Qiu, Xintao;
Tewari, Alok K.;
Shah, Neel;
Nguyen, Holly M.;
Patel, Radhika A.;
Brown, Lisha;
Coleman, Ilsa;
Hackeng, Wenzel M.;
Brosens, Lodewijk;
Dreijerink, Koen M. A.;
Ellis, Leigh;
Alaiwi, Sarah Abou;
Seo, Ji-Heui;
Baca, Sylvan;
Beltran, Himisha

Publication type:

Article

Molecular profiling stratifies diverse phenotypes of treatment-refractory metastatic castration-resistant prostate cancer.

Published in:

2019

By:

Labrecque, Mark P.;
Coleman, Ilsa M.;
Brown, Lisha G.;
True, Lawrence D.;
Kollath, Lori;
Lakely, Bryce;
Nguyen, Holly M.;
Yu C. Yang;
Gil da Costa, Rui M.;
Kaipainen, Arja;
Coleman, Roger;
Higano, Celestia S.;
Yu, Evan Y.;
Cheng, Heather H.;
Mostaghel, Elahe A.;
Montgomery, Bruce;
Schweizer, Michael T.;
Hsieh, Andrew C.;
Lin, Daniel W.;
Corey, Eva

Publication type:

journal article

Castration resistance in human prostate cancer is conferred by a frequently occurring androgen receptor splice variant.

Published in:

2010

By:

Sun, Shihua;
Sprenger, Cynthia C. T.;
Vessella, Robert L.;
Haugk, Kathleen;
Soriano, Kathryn;
Mostaghel, Elahe A.;
Page, Stephanie T.;
Coleman, Ilsa M.;
Nguyen, Holly M.;
Sun, Huiying;
Nelson, Peter S.;
Plymate, Stephen R.

Publication type:

journal article

Inhibition of CCL2 Signaling in Combination with Docetaxel Treatment Has Profound Inhibitory Effects on Prostate Cancer Growth in Bone.

Published in:

International Journal of Molecular Sciences, 2013, v. 14, n. 5, p. 10483, doi. 10.3390/ijms140510483

By:

Kirk, Peter S.;
Koreckij, Theodore;
Nguyen, Holly M.;
Brown, Lisha G.;
Snyder, Linda A.;
Vessella, Robert L.;
Corey, Eva

Publication type:

Article

Movember GAP1 PDX project: An international collection of serially transplantable prostate cancer patient‐derived xenograft (PDX) models.

Published in:

Prostate, 2018, v. 78, n. 16, p. 1262, doi. 10.1002/pros.23701

By:

Navone, Nora M.;
van Weerden, Wytske M.;
Vessella, Robert L.;
Williams, Elizabeth D.;
Wang, Yuzhuo;
Isaacs, John T.;
Nguyen, Holly M.;
Culig, Zoran;
van der Pluijm, Gabri;
Rentsch, Cyril A.;
Marques, Rute B.;
de Ridder, Corrina M. A.;
Bubendorf, Lukas;
Thalmann, George N.;
Brennen, William Nathaniel;
Santer, Frédéric R.;
Moser, Patrizia L.;
Shepherd, Peter;
Efstathiou, Eleni;
Xue, Hui

Publication type:

Article

LuCaP Prostate Cancer Patient-Derived Xenografts Reflect the Molecular Heterogeneity of Advanced Disease and Serve as Models for Evaluating Cancer Therapeutics.

Published in:

Prostate, 2017, v. 77, n. 6, p. 654, doi. 10.1002/pros.23313

By:

Nguyen, Holly M.;
Vessella, Robert L.;
Morrissey, Colm;
Brown, Lisha G.;
Coleman, Ilsa M.;
Higano, Celestia S.;
Mostaghel, Elahe A.;
Zhang, Xiaotun;
True, Lawrence D.;
Lam, Hung‐Ming;
Roudier, Martine;
Lange, Paul H.;
Nelson, Peter S.;
Corey, Eva

Publication type:

Article

Addition of PSMA ADC to enzalutamide therapy significantly improves survival in in vivo model of castration resistant prostate cancer.

Published in:

Prostate, 2016, v. 76, n. 3, p. 325, doi. 10.1002/pros.23124

By:

DiPippo, Vincent A.;
Nguyen, Holly M.;
Brown, Lisha G.;
Olson, William C.;
Vessella, Robert L.;
Corey, Eva

Publication type:

Article

Efficacy studies of an antibody-drug conjugate PSMA-ADC in patient-derived prostate cancer xenografts.

Published in:

Prostate, 2015, v. 75, n. 3, p. 303, doi. 10.1002/pros.22916

By:

DiPippo, Vincent A.;
Olson, William C.;
Nguyen, Holly M.;
Brown, Lisha G.;
Vessella, Robert L.;
Corey, Eva

Publication type:

Article

Establishment and serial passage of cell cultures derived from LuCaP xenografts.

Published in:

Prostate, 2013, v. 73, n. 12, p. 1251, doi. 10.1002/pros.22610

By:

Young, Sarah R.;
Saar, Matthias;
Santos, Jennifer;
Nguyen, Holly M.;
Vessella, Robert L.;
Peehl, Donna M.

Publication type:

Article

ACAA2 is a novel molecular indicator for cancers with neuroendocrine phenotype.

Published in:

British Journal of Cancer, 2023, v. 129, n. 11, p. 1818, doi. 10.1038/s41416-023-02448-y

By:

Shen, Michelle;
Liu, Shiqin;
Toland, Angus;
Hsu, En-Chi;
Hartono, Alifiani B.;
Alabi, Busola R.;
Aslan, Merve;
Nguyen, Holly M.;
Sessions, Conner J.;
Nolley, Rosalie;
Shi, Chanjuan;
Huang, Jiaoti;
Brooks, James D.;
Corey, Eva;
Stoyanova, Tanya

Publication type:

Article

Conversion of Prostate Adenocarcinoma to Small Cell Carcinoma-Like by Reprogramming.

Published in:

Journal of Cellular Physiology, 2016, v. 231, n. 9, p. 2040, doi. 10.1002/jcp.25313

By:

Borges, Gisely T.;
Vêncio, Eneida F.;
Quek, Sue‐Ing;
Chen, Adeline;
Salvanha, Diego M.;
Vêncio, Ricardo Z.N.;
Nguyen, Holly M.;
Vessella, Robert L.;
Cavanaugh, Christopher;
Ware, Carol B.;
Troisch, Pamela;
Liu, Alvin Y.

Publication type:

Article

A bladder cancer patient-derived xenograft displays aggressive growth dynamics in vivo and in organoid culture.

Published in:

Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-83662-7

By:

Cai, Elise Y.;
Garcia, Jose;
Liu, Yuzhen;
Vakar-Lopez, Funda;
Arora, Sonali;
Nguyen, Holly M.;
Lakely, Bryce;
Brown, Lisha;
Wong, Alicia;
Montgomery, Bruce;
Lee, John K.;
Corey, Eva;
Wright, Jonathan L.;
Hsieh, Andrew C.;
Lam, Hung-Ming

Publication type:

Article

Cabozantinib Inhibits Growth of Androgen-Sensitive and Castration-Resistant Prostate Cancer and Affects Bone Remodeling.

Published in:

PLoS ONE, 2013, v. 8, n. 10, p. 1, doi. 10.1371/journal.pone.0078881

By:

Nguyen, Holly M.;
Ruppender, Nazanin;
Zhang, Xiaotun;
Brown, Lisha G.;
Gross, Ted S.;
Morrissey, Colm;
Gulati, Roman;
Vessella, Robert L.;
Schimmoller, Frauke;
Aftab, Dana T.;
Corey, Eva

Publication type:

Article

MCM2-7 complex is a novel druggable target for neuroendocrine prostate cancer.

Published in:

Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-92552-x

By:

Hsu, En-Chi;
Shen, Michelle;
Aslan, Merve;
Liu, Shiqin;
Kumar, Manoj;
Garcia-Marques, Fernando;
Nguyen, Holly M.;
Nolley, Rosalie;
Pitteri, Sharon J.;
Corey, Eva;
Brooks, James D.;
Stoyanova, Tanya

Publication type:

Article

Cabozantinib can block growth of neuroendocrine prostate cancer patient-derived xenografts by disrupting tumor vasculature.

Published in:

PLoS ONE, 2021, v. 16, n. 1, p. 1, doi. 10.1371/journal.pone.0245602

By:

Labrecque, Mark P.;
Brown, Lisha G.;
Coleman, Ilsa M.;
Nguyen, Holly M.;
Lin, Daniel W.;
Corey, Eva;
Nelson, Peter S.;
Morrissey, Colm

Publication type:

Article

Targeting the fibroblast growth factor pathway in molecular subtypes of castration‐resistant prostate cancer.

Published in:

Prostate, 2024, v. 84, n. 1, p. 100, doi. 10.1002/pros.24630

By:

Labrecque, Mark P.;
Brown, Lisha G.;
Coleman, Ilsa M.;
Nguyen, Holly M.;
Dalrymple, Susan;
Brennen, W. Nathaniel;
Isaacs, John T.;
Li, Dapei;
Lakely, Bryce;
DeLucia, Diana C.;
Lee, John K.;
Schweizer, Michael T.;
Lin, Daniel W.;
Corey, Eva;
Nelson, Peter S.;
Morrissey, Colm

Publication type:

Article